하트 행크스, Inc.
| Security | HHS / Harte Hanks, Inc. |
| Insider | Melvin L Keating |
This page shows the track record and history of KEATING MELVIN L
insider trades in Harte Hanks, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Melvin L Keating in HHS / Harte Hanks, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Melvin L Keating in HHS / Harte Hanks, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-01 | 2020-07-22 | 4 | KEATING MELVIN L | HRTH | Restricted Stock Units | D | -6,684 | 0 | ||||||
| 2020-09-01 | 2020-07-22 | 4 | KEATING MELVIN L | HRTH | Common Stock | D | 6,684 | 38,676 | ||||||
| 2020-09-01 | 2020-03-21 | 4 | KEATING MELVIN L | HRTH | Restricted Stock Units | D | -23,136 | 0 | ||||||
| 2020-09-01 | 2020-03-21 | 4 | KEATING MELVIN L | HRTH | Common Stock | D | 23,136 | 31,992 | ||||||
| 2019-03-28 | 2019-03-21 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 23,136 | 38,676 | ||||||
| 2019-01-03 | 2019-01-03 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 2.4200 | 1,355 | 3 | 4,450 | ||||
| 2018-10-02 | 2018-09-28 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 7.1300 | 460 | 3 | 3,095 | ||||
| 2018-08-03 | 2018-08-03 | 4 | KEATING MELVIN L | HHS | Restricted Stock Units | D | -2,127 | 4,255 | ||||||
| 2018-08-03 | 2018-08-03 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 2,127 | 2,635 | ||||||
| 2018-07-30 | 2018-07-27 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 6,835 | 13,725 | ||||||
| 2018-07-16 | 2018-07-16 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 11.1000 | 236 | 3 | 508 | ||||
| 2018-04-13 | 2018-04-13 | 4 | KEATING MELVIN L | HHS | Common Stock | D | 9.1600 | 272 | 2 | 272 | ||||
| 2017-08-04 | 2017-08-03 | 4 | KEATING MELVIN L | HHS | Restricted Stock Units | D | 63,829 | 63,829 | ||||||
| 2017-07-21 | 3 | KEATING MELVIN L | HHS | No Securities Are Beneficially Owned | D | 0 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
